Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AIMDW
Ainos
$0.12
+0.2%
$0.14
$0.03
$0.37
N/AN/A16,790 shs100 shs
Bone Biologics Co. stock logo
BBLGW
Bone Biologics
$15.00
+11.1%
$14.54
$3.00
$95.04
N/AN/A1,915 shs200 shs
BICO Group AB (publ) stock logo
CLLKF
BICO Group AB (publ)
C$3.83
-1.3%
C$3.72
C$2.59
C$5.60
N/AN/A1,854 shs480 shs
Vitrolife AB (publ) stock logo
VTRLY
Vitrolife AB (publ)
$14.98
$15.93
$14.62
$17.66
N/AN/A133 shsN/A
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AIMDW
Ainos
-0.17%-20.13%+13.55%+110.18%+73.88%
Bone Biologics Co. stock logo
BBLGW
Bone Biologics
0.00%0.00%+11.11%-25.74%-65.52%
BICO Group AB (publ) stock logo
CLLKF
BICO Group AB (publ)
-1.29%+2.41%+0.02%+11.34%-2.05%
Vitrolife AB (publ) stock logo
VTRLY
Vitrolife AB (publ)
0.00%+0.54%-8.60%-16.78%-7.82%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
AIMDW
Ainos
N/AN/AN/AN/AN/AN/AN/AN/A
Bone Biologics Co. stock logo
BBLGW
Bone Biologics
N/AN/AN/AN/AN/AN/AN/AN/A
BICO Group AB (publ) stock logo
CLLKF
BICO Group AB (publ)
N/AN/AN/AN/AN/AN/AN/AN/A
Vitrolife AB (publ) stock logo
VTRLY
Vitrolife AB (publ)
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
AIMDW
Ainos
0.00
N/AN/AN/A
Bone Biologics Co. stock logo
BBLGW
Bone Biologics
0.00
N/AN/AN/A
BICO Group AB (publ) stock logo
CLLKF
BICO Group AB (publ)
0.00
N/AN/AN/A
Vitrolife AB (publ) stock logo
VTRLY
Vitrolife AB (publ)
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
AIMDW
Ainos
$106.21KN/AN/AN/AN/AN/A
Bone Biologics Co. stock logo
BBLGW
Bone Biologics
N/AN/AN/AN/AN/AN/A
BICO Group AB (publ) stock logo
CLLKF
BICO Group AB (publ)
N/AN/AN/AN/AN/AN/A
Vitrolife AB (publ) stock logo
VTRLY
Vitrolife AB (publ)
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
AIMDW
Ainos
N/AN/A0.00N/AN/AN/AN/AN/A
Bone Biologics Co. stock logo
BBLGW
Bone Biologics
N/AN/A0.00N/AN/AN/AN/AN/A
BICO Group AB (publ) stock logo
CLLKF
BICO Group AB (publ)
N/AN/A0.00N/AN/AN/AN/AN/A
Vitrolife AB (publ) stock logo
VTRLY
Vitrolife AB (publ)
N/AN/A0.00N/AN/AN/AN/A7/17/2025 (Estimated)
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
AIMDW
Ainos
N/AN/AN/AN/AN/A
Bone Biologics Co. stock logo
BBLGW
Bone Biologics
N/AN/AN/AN/AN/A
BICO Group AB (publ) stock logo
CLLKF
BICO Group AB (publ)
N/AN/AN/AN/AN/A
Vitrolife AB (publ) stock logo
VTRLY
Vitrolife AB (publ)
N/AN/AN/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
AIMDW
Ainos
N/A
Bone Biologics Co. stock logo
BBLGW
Bone Biologics
N/A
BICO Group AB (publ) stock logo
CLLKF
BICO Group AB (publ)
N/A
Vitrolife AB (publ) stock logo
VTRLY
Vitrolife AB (publ)
N/A

Insider Ownership

CompanyInsider Ownership
AIMDW
Ainos
N/A
Bone Biologics Co. stock logo
BBLGW
Bone Biologics
N/A
BICO Group AB (publ) stock logo
CLLKF
BICO Group AB (publ)
N/A
Vitrolife AB (publ) stock logo
VTRLY
Vitrolife AB (publ)
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
AIMDW
Ainos
40N/AN/ANot Optionable
Bone Biologics Co. stock logo
BBLGW
Bone Biologics
2N/AN/ANot Optionable
BICO Group AB (publ) stock logo
CLLKF
BICO Group AB (publ)
880N/AN/ANot Optionable
Vitrolife AB (publ) stock logo
VTRLY
Vitrolife AB (publ)
1,132N/AN/ANot Optionable

Recent News About These Companies

Vitrolife AB
Election committee for Vitrolife AB (publ)
Vitrolife Group Annual and Sustainability Report 2022
Vitrolife: Conference call interim report
Report from Annual General Meeting of Vitrolife AB (publ)
Conference call interim report: Vitrolife AB (publ)
CEO has purchased shares in Vitrolife AB

Media Sentiment Over Time

Ainos NASDAQ:AIMDW

$0.12 +0.00 (+0.17%)
As of 11:21 AM Eastern

Ainos, Inc., a healthcare company, engages in developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a's broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan. It also provides women's health, pneumonia, Ainos Pen, AI Nose, and other products. Ainos, Inc. was formerly known as Amarillo Biosciences, Inc. and changed its name to Ainos, Inc. in May 2021. The company was incorporated in 1984 and is based in San Diego, California.

Bone Biologics stock logo

Bone Biologics NASDAQ:BBLGW

$15.00 +1.50 (+11.11%)
As of 07/7/2025

Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBM, an osteopromotive recombinant protein that provides target specific control over bone regeneration. It also develops NELL-1/DBM Fusion Device for use in spinal fusion procedures in skeletally mature patients with spinal degenerative disc disease at one level from L2-S1. The company's platform technology is used in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. It has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications. Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts.

BICO Group AB (publ) stock logo

BICO Group AB (publ) OTCMKTS:CLLKF

C$3.83 -0.05 (-1.29%)
As of 07/7/2025 01:15 PM Eastern

BICO Group AB (publ) operates as a bioconvergence company in North America, Europe, Asia, and internationally. It operates through three segments: Bioprinting, Biosciences, and Bioautomation. The Bioprinting segment offers products, solutions, and services that enable proliferation of 3D cell culture and 3D printing. The Biosciences segment provides instruments that enable the handling of cells and rare samples, and rapid transfer of liquids and reagents, as well as downstream analysis platforms. The Bioautomation segment offers end-to-end products and services in precision dispensing, advanced sample preparation, multiplex analysis and assay miniaturization, diagnostic and medical device manufacturing for life science and diagnostic industries. It primarily serves medical, pharmaceutical, and cosmetic industries. The company offers its products through sales organizations, as well as through an extensive distributor network. The company was formerly known as Cellink AB (publ) and changed its name to BICO Group AB (publ) in August 2021. BICO Group AB (publ) was incorporated in 2016 and is headquartered in Gothenburg, Sweden.

Vitrolife AB (publ) stock logo

Vitrolife AB (publ) OTCMKTS:VTRLY

$14.98 0.00 (0.00%)
As of 07/3/2025

Vitrolife AB (publ) provides assisted reproduction products. It also offers sperm processing, oocyte retrieval needles, micromanipulation pipettes, time-lapse systems, and evaluation tools, laser and imaging systems, IVF media and oil, embryo transfer, cryopreservation, and genomics kits. In addition, the company offers EmbryoScope and time-lapse systems; time-lapse dishes; and evaluation tools for time-lapse systems. The company operates in Europe, the Middle East, India and Africa; Asia; Japan and Pacific; Americas; and Asia. Vitrolife AB (publ) was founded in 1994 and is based in Gothenburg, Sweden.